⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19387469 | 0.78 | — | — | |
| SCHEMBL4407663 | 0.76 | CA1 (0.31) | — | |
| SCHEMBL16611562 | 0.74 | — | — | |
| SCHEMBL4404525 | 0.72 | — | — | |
| SCHEMBL9665524 | 0.69 | CA1 (0.45) | — | |
| SCHEMBL779252 | 0.69 | — | — | |
| SCHEMBL4412574 | 0.69 | — | — | |
| SCHEMBL1446020 | 0.69 | GRIA1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL17258785 | 0.67 | — | — | |
| SCHEMBL1259452 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090304631-A1 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PHENOMIX CORPORATION | 2009-12-10 | — | — | US | claimed |
| EP-2029153-A2 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | Phenomix Corporation (US) | 2009-03-04 | — | — | EP | claimed |
| WO-2007089618-A2 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PHENOMIX CORPORATION (US) | 2007-08-09 | — | — | WO | claimed |